Condition: Chronic Spontaneous Urticaria · Sponsor: Bambusa Therapeutics
This is a Phase IIa, randomized, blinded, placebo controlled,Multiple-Ascending Dose study of BBT001 in adult patients with Chronic Spontaneous Urticaria.
This description comes directly from the study's public registry record.
Tracy Ji, Study Director · +86 18001322760 · tracy.ji@bambusatx.com
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital of Wannan Medical College | Wuhu, Anhui, China | Not Yet Recruiting |
| Peking University People's Hospital, Beijing | Beijing, Beijing Municipality, China | Recruiting |
| The Second Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Dermatology Hospital of Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The First Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Not Yet Recruiting |
| Jingzhou Central Hospital | Jinzhou, Hubei, China | Not Yet Recruiting |
| Wuxi Second People's Hospital, | Wuxi, Jiangsu, China | Not Yet Recruiting |
| The Second Hospital of Shanxi Medical University | Taiyuan, Shanxi, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Xi'an Jiaotong University | Xi’an, Shanxi, China | Not Yet Recruiting |
| Hangzhou Third People's Hospital | Hangzhou, Zhejiang, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07717905